In the world of cannabis, THC (tetrahydrocannabinol) is the most well-known psychoactive substance. It is often associated with the high experienced when consuming certain cannabis strains. However, there is another substance that is attracting the interest of researchers and the cannabis industry: THCP ( tetrahydrocannabiphorol). In this article, we present the main differences between these two compounds and why you should be interested in the potential of THCP.
Chemical structure, biosynthesis and mode of action: a comparison between THC and THCP
THCP shares many similarities with THC, particularly in its chemical structure. Indeed, both molecules belong to the phytocannabinoid family found in the cannabis plant. Their main difference lies in their alkyl chain, which is composed of three carbon atoms for THC (cielhexyl) and seven carbon atoms for THCP (heptyl).
The production of THCP: a complex synthesis
Regarding the biosynthesis of THCP, this substance is produced from cannabigerovarine acid (CBGV) when the cannabis plant is subjected to environmental stress. THCP production is therefore more complex and less frequent than that of THC, which occurs during the natural decarboxylation of cannabigerol (CBG).
Different psychoactive effects
The psychoactive effects of the two substances are also distinct. While THC is known for its psychotropic potential, early studies on THCP suggest it could be up to 30 times more potent than THC. This discovery has piqued the interest of several scientists who want to learn more about the potential medical and therapeutic implications of this substance.
Medical and therapeutic potential: what we know about THCP
As with many other molecules found in cannabis, the medical and therapeutic potential of these two phytocannabinoids is generating considerable interest among researchers and the pharmaceutical industry. However, the full range of beneficial properties that THCP might offer compared to THC remains to be explored.
An increased analgesic effect with THCP?
The analgesic (pain-relieving) properties of THC and THCP may vary considerably due to their structural differences and mechanisms of action. Current research shows that THCP has a greater affinity for the CB1 receptor in the brain, which is specialized for analgesics. This could mean that pain is better managed or relieved by THCP than by THC, but this remains to be confirmed.
Could it help with anxiety and mood disorders?
Furthermore, the potential of both substances to treat anxiety and mood disorders is also being explored, although no studies have yet directly addressed this issue. However, it would appear that THCP offers interesting therapeutic potential in this area, due to its high affinity for CB1 receptors present in the central nervous system.
Legality and availability: where to find THCP compared to THC?
Although both are derived from the cannabis plant, THC and THCP have distinct legal statuses depending on the country. THC is generally prohibited or heavily regulated due to its psychoactive effects and potential for abuse, while THCP remains relatively unknown and regulated compared to its more famous cousin.
THC: strictly regulated legislation
Most countries restrict the use and distribution of products containing a concentration of THC above a specific threshold (often between 0.2% and 1%), such as certain cannabis-based medical preparations or legally sold cannabidiol (CBD) products.
Market emergence and regulation for THCP
As for THCP, little information is available on its presence in current cannabis varieties. Consequently, there is currently no specific legislation regarding its maximum permitted concentration in cannabinoid-containing products. However, with the rise of the cannabis industry and the increasing diversification of products offered, it is likely that THCP will soon be among the substances subject to regulation.
Implications for the cannabis industry: a promising innovation?
The recent rise of the CBD sector, thanks to its commercial success, underscores the ongoing desire toexplore new molecules derived from cannabis. THCP could thus represent a new flagship compound in this industry, offering distinct and potentially superior therapeutic properties compared to those already observed with other cannabinoids.
From plant selection to medical applications
Advances in the knowledge and understanding of THCP could lead to changes in cannabis plant breeding and the formulation of their derivatives, with a greater focus on research and development of THCP-rich strains. Future discoveries regarding the mechanism of action and health benefits of this molecule could also contribute to the evolution of cannabis-based medical and therapeutic treatments.
A market that is still expanding
Finally, THCP could represent a key compound for companies in the sector seeking to create increasingly innovative and diverse new products. These companies could then offer different therapeutic solutions tailored to consumers' needs and concerns, fostering a growing personalization of cannabis-derived products.
Editor-in-Chief specializing in CBD
Julien, born on July 17, 1978, in the Paris region, is a prominent writer and expert in the field of CBD products. Following his studies, Julien developed a passion for natural remedies, including CBD. In 2022, he joined the CBD.fr team as an expert and regular contributor. Thanks to his scientific expertise and clear writing style, Julien helps demystify the complexities of CBD, while highlighting its benefits and potential applications through his articles and conference presentations.
